➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Merck
Medtronic
AstraZeneca
McKinsey

Last Updated: July 11, 2020

DrugPatentWatch Database Preview

PROVENTIL Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Proventil, and what generic alternatives are available?

Proventil is a drug marketed by Schering and Kindeva and is included in six NDAs.

The generic ingredient in PROVENTIL is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

US ANDA Litigation and Generic Entry Outlook for Proventil

A generic version of PROVENTIL was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.

  Start Trial

Drug patent expirations by year for PROVENTIL
Drug Prices for PROVENTIL

See drug prices for PROVENTIL

Drug Sales Revenue Trends for PROVENTIL

See drug sales revenues for PROVENTIL

Recent Clinical Trials for PROVENTIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
West Penn Allegheny Health SystemPhase 4
Asthma Management SystemsPhase 4
Merck Sharp & Dohme Corp.Phase 4

See all PROVENTIL clinical trials

US Patents and Regulatory Information for PROVENTIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering PROVENTIL albuterol AEROSOL, METERED;INHALATION 017559-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Schering PROVENTIL albuterol sulfate TABLET;ORAL 017853-002 May 7, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Schering PROVENTIL albuterol sulfate SYRUP;ORAL 018062-001 Jan 19, 1983 DISCN Yes No   Start Trial   Start Trial   Start Trial
Kindeva PROVENTIL-HFA albuterol sulfate AEROSOL, METERED;INHALATION 020503-001 Aug 15, 1996 AB1 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PROVENTIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering PROVENTIL albuterol sulfate SOLUTION;INHALATION 019243-001 Jan 14, 1987   Start Trial   Start Trial
Schering PROVENTIL albuterol AEROSOL, METERED;INHALATION 017559-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Schering PROVENTIL albuterol sulfate SYRUP;ORAL 018062-001 Jan 19, 1983   Start Trial   Start Trial
Schering PROVENTIL albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019383-001 Jul 13, 1987   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Merck
Medtronic
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.